Gene · 64321
Papers4,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer. | Exp Mol Med | 2022 | 35729325 | PubTator, text mining | PubMed |
| NANOG initiates epiblast fate through the coordination of pluripotency genes expression. | Nat Commun | 2022 | 35729116 | PubTator, text mining | PubMed |
| Generation of a homozygous knock-in human embryonic stem cell line expressing mEos4b-tagged CTR1. | Stem Cell Res | 2022 | 35728441 | PubTator, text mining | PubMed |
| Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions. | Br J Cancer | 2022 | 35725812 | PubTator, text mining | PubMed |
| Endothelial and hematopoietic hPSCs differentiation via a hematoendothelial progenitor. | Stem Cell Res Ther | 2022 | 35715824 | PubTator, text mining | PubMed |
| Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma. | Front Genet | 2022 | 35711943 | PubTator, text mining | PubMed |
| Establishment and characterization of a novel human induced pluripotent stem cell line stably expressing the iRFP720 reporter. | Sci Rep | 2022 | 35701501 | PubTator, text mining | PubMed |
| An induced pluripotent stem cell line (CIMRi001-A) from a Vici syndrome donor with a homozygous recessive c.1007A>G (p.Q336R) mutation in the EPG5 gene. | Stem Cell Res | 2022 | 35700637 | PubTator, text mining | PubMed |
| Generation of two induced pluripotent stem cell lines carrying the phospholamban R14del mutation for modeling ARVD/C. | Stem Cell Res | 2022 | 35700631 | PubTator, text mining | PubMed |
| Integrated multi-omics reveal polycomb repressive complex 2 restricts human trophoblast induction. | Nat Cell Biol | 2022 | 35697783 | PubTator, text mining | PubMed |
| Enhanced cortical neural stem cell identity through short SMAD and WNT inhibition in human cerebral organoids facilitates emergence of outer radial glial cells. | Nat Cell Biol | 2022 | 35697781 | PubTator, text mining | PubMed |
| Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer. | Transl Lung Cancer Res | 2022 | 35693293 | PubTator, text mining | PubMed |
| Using liver models generated from human-induced pluripotent stem cells (iPSCs) for evaluating chemical-induced modifications and disease across liver developmental stages. | Toxicol In Vitro | 2022 | 35688329 | PubTator, text mining | PubMed |
| CRISPR-AsCas12a Efficiently Corrects a GPR143 Intronic Mutation in Induced Pluripotent Stem Cells from an Ocular Albinism Patient. | CRISPR J | 2022 | 35686978 | PubTator, text mining | PubMed |
| Expression Profile and Diagnostic Significance of MicroRNAs in Papillary Thyroid Cancer. | Cancers (Basel) | 2022 | 35681658 | PubTator, text mining | PubMed |
| Clinical Value and Molecular Function of Circulating MicroRNAs in Endometrial Cancer Regulation: A Systematic Review. | Cells | 2022 | 35681531 | PubTator, text mining | PubMed |
| Efficient generation of functional pancreatic β cells from dental-derived stem cells via laminin-induced differentiation. | J Genet Eng Biotechnol | 2022 | 35674918 | PubTator, text mining | PubMed |
| DNA methylation in pulmonary fibrosis and lung cancer. | Expert Rev Respir Med | 2022 | 35673969 | PubTator, text mining | PubMed |
| Educational Case: Classic seminoma of the testis. | Acad Pathol | 2022 | 35669407 | PubTator, text mining | PubMed |
| Cell-free DNA as a Promising Diagnostic Biomarker in Prostate Cancer: A Systematic Review and Meta-Analysis. | J Oncol | 2022 | 35669243 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/papers?page=51